Emil Lou
Division of Hematology, Oncology, and Transplantation, University of Minnesota · Division of Hematology, Oncology and Transplantation, University of Minnesota
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Emil Lou as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 20:57 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05566223 · CISH Inactivated TILs in the Treatment of NSCLCIntima Bioscience, Inc. · withdrawn · Carcinoma, Non-Small-Cell Lung, Metastatic Non Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer · principal investigator
- Ph1/Ph2NCT04426669 · A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic EngineeringIntima Bioscience, Inc. · completed · Gastrointestinal Epithelial Cancer, Gastrointestinal Neoplasms, Cancer of Gastrointestinal Tract · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 20:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 20:57 UTC. The ranking covers the 200 most relevant of 20 PubMed records, and a shared surname and initials can bring in a namesake. All 20 on PubMed
- 147 citationsRCR 10.8
- Trunk distortion in adolescent idiopathic scoliosis.J Pediatr Orthop · 1998122 citationsRCR 6.9
- Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients.Br J Cancer · 201269 citationsRCR 2.0
- 55 citationsRCR 10.6
- Whether Orthotic Management and Exercise are Equally Effective to the Patients With Adolescent Idiopathic Scoliosis in Mainland China?: A Randomized Controlled Trial Study.Spine (Phila Pa 1976) · 201844 citationsRCR 4.3
- An objective measurement of brace usage for the treatment of adolescent idiopathic scoliosis.Med Eng Phys · 201141 citationsRCR 2.4
- Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma.Cancer Med · 201339 citationsRCR 1.3
- Effect of Schroth exercises on curve characteristics and clinical outcomes in adolescent idiopathic scoliosis: protocol for a multicentre randomised controlled trial.J Physiother · 201436 citationsRCR 2.2
- Evaluation of a laser scanner for surface topography.Stud Health Technol Inform · 200233 citationsRCR 1.8
- Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable Glioblastoma.Oncologist · 201524 citationsRCR 0.8